TLPH

TALPHERA, INC.
—

Company Information

Company Name
TALPHERA, INC.
CIK
CIK0001427925
Category
Non-accelerated filer<br>Smaller reporting company
Ticker: Exchange
TLPH: Nasdaq
Fiscal Year End
December 31
Owner Organization
03 Life Sciences
SIC
2834
SIC Description
Pharmaceutical Preparations
Ticker
TLPH

SEC filing data through

Insider Sentiment

Last purchase
2026-03-13
Last sale
2024-12-02
Shares purchased (TTM)
646,984
Shares sold (TTM)
0
Buy ratio (TTM)100.0%

Institutional Sentiment

As of
2026-06-30
Institutional shares owned
23,567,074
Shares outstanding
75,526,900
Ownership
31.20%
+15.90% Y/Y

Earnings Market Reaction

Filing date
2026-08-12
Price on filing date
—
1-month reaction
-14.29%
3-month reaction
…
Drift continued7/9 (78%)
Faded / reversed2/9 (22%)

Balance Sheet

Values in millions ($)
Line item2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-302024-03-312023-12-312023-09-30Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only columnTrend
Assets
Cash And Cash Equivalents At Carrying Value1463759111312613
Short Term Investments16171418--001640
Prepaid Expense And Other Assets Current101111112121
Restricted Cash Current----------00
Assets Current182121228691216201214
Intangible Assets Net Excluding Goodwill999999999999
Assets273030311715182125292023
Assets Of Disposal Group Including Discontinued Operation Current----------00
Liabilities Current
Accounts Payable Current011110101111
Other Assets Noncurrent----------00
Accrued Liabilities Current323211122122
Liabilities Of Disposal Group Including Discontinued Operation Current111111111111
Disposal Group Including Discontinued Operation Assets Noncurrent----------00
Liabilities Current444332333354
Warrants And Rights Outstanding212211122321
Liabilities121213121091011121265
Long Term Debt Current----------00
Stockholders Equity
Common Stock Value000000000000
Additional Paid In Capital493493489487470465465465465464458458
Other Liabilities Noncurrent----------00
Retained Earnings Accumulated Deficit-478-474-472-468-463-460-457-455-452-448-444-440
Liabilities Of Disposal Group Including Discontinued Operation Noncurrent----------00
Stockholders Equity141817197681013161418
Liabilities And Stockholders Equity273030311715182125292023
Common Stock Par Or Stated Value Per Share0.000.000.000.000.000.000.000.000.000.000.000.00
Common Stock Shares Authorized200200200200200200200200200200200200
Common Stock Shares Issued525049462117171717171717
Shares Outstanding525049462117171717171717

Select a line item above to chart it.

Recent filings

Financial statements beyond 3 years are for subscribers only.

Unlock 17+ years of income statements, balance sheets, and cash flow statements

Start 7-day free trial

TALPHERA, INC. (TLPH) — SEC Financial Statements & Analysis

TALPHERA, INC. (TLPH) is a pharmaceutical preparations company, incorporated in DE. TALPHERA, INC. trades on Nasdaq as: TLPH. TALPHERA, INC. (TLPH)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-12. Based on that filing, TALPHERA, INC. carries a market cap of $77.79M, a P/E ratio of -5.16x, a P/B ratio of 5.40x, a P/S ratio of 77792.70x, an enterprise value of $77.05M, and an EV/EBITDA multiple of -5.22x. On profitability, it posts an operating margin of -1474700.00%, a net margin of -1507600.00%, a Return on Equity (ROE) of -143.36%, a Return on Assets (ROA) of -69.60%, and a Return on Invested Capital (ROIC) of -218.47%. Per share, it reports EPS of $-0.20, diluted EPS of $-1.29, free cash flow per share of $-0.16, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of -96.30% year-over-year, net income growth of 33.36% year-over-year, and EPS growth of -39.03% year-over-year. On the balance sheet, it maintains a current ratio of 4.29x, a quick ratio of 4.08x, working capital of $13.80M, a debt-to-equity ratio of 0.86x, a debt ratio of 0.46, an interest coverage ratio of -138.98x, free cash flow of $-12.27M (TTM), and net debt of $-742.00K. Figures sourced from SEC EDGAR.

Market Cap
$77.79M
P/E TTM
-5.16x
EPS TTM
$-0.20
P/B TTM
5.40x
ROE TTM
-143.36%
ROA TTM
-69.60%
Debt To Equity
0.86x
Free Cash Flow TTM
$-12.27M
Net Revenue TTM Growth 1Y
-96.30%

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is TALPHERA, INC. in?

TALPHERA, INC. (TLPH) operates in the Pharmaceutical Preparations industry.

What exchange does TLPH trade on?

TALPHERA, INC. (TLPH) trades on the Nasdaq.

Where is TALPHERA, INC. incorporated?

TALPHERA, INC. is incorporated in DE.

When was TALPHERA, INC. (TLPH)'s most recent SEC filing?

TALPHERA, INC. (TLPH)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-12.

What is TLPH's market cap?

TALPHERA, INC. (TLPH) has a market capitalization of $77.79M as of 2026-06-30.

What is TLPH's EPS (earnings per share)?

TALPHERA, INC. (TLPH)'s trailing twelve month EPS is $-0.20 as of 2026-06-30.

What is TLPH's ROE (return on equity)?

TALPHERA, INC. (TLPH)'s trailing twelve month Return on Equity (ROE) is -143.36% as of 2026-06-30.

What is TLPH's ROA (return on assets)?

TALPHERA, INC. (TLPH)'s trailing twelve month Return on Assets (ROA) is -69.60% as of 2026-06-30.

What is TLPH's ROIC (return on invested capital)?

TALPHERA, INC. (TLPH)'s trailing twelve month Return on Invested Capital (ROIC) is -218.47% as of 2026-06-30.

What is TLPH's EV/EBITDA?

TALPHERA, INC. (TLPH)'s trailing twelve month EV/EBITDA is -5.22x as of 2026-06-30.

Wall Street's data.
Main Street's price.